Darbepoetin alfa
RxNorm 283838
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 283838 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: darbepoetin alfa.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
INPrescribable
Ingredient (IN):
Darbepoetin alfa
(Atom ID: 1355604)
PTPrescribable
Designated preferred name (PT):
Darbepoetin alfa
(Atom ID: 1355608)
FNPrescribable
Full form of descriptor (FN):
Darbepoetin alfa (substance)
(Atom ID: 1355611)
PTPrescribable
Designated preferred name (PT):
Darbepoetin alfa-containing product
(Atom ID: 10800737)
FNPrescribable
Full form of descriptor (FN):
Product containing darbepoetin alfa (medicinal product)
(Atom ID: 9723982)
Patient Education
Darbepoetin Alfa Injection
Darbepoetin alfa injection is used to treat anemia (a lower than normal number of red blood cells) in people with chronic kidney failure (condition in which the kidneys slowly and permanently stop working over a period of time). Darbepoetin alfa injection is also used to treat anemia caused by chemotherapy in people with certain types of cancer. Darbepoetin alfa cannot be used in place of a red blood cell transfusion to treat severe anemia and has not been shown to improve tiredness or poor well-being that may be caused by anemia. Darbepoetin alfa is in a class of medications called erythropoiesis-stimulating agents (ESAs). It works by causing the bone marrow (soft tissue inside the bones where blood is made) to make more red blood cells.
[Learn More]
* Please review the disclaimer below.